Piper Sandler Maintains Neutral Rating on e.l.f. Beauty Following February Data Adjustments
Money

Piper Sandler Maintains Neutral Rating on e.l.f. Beauty Following February Data Adjustments

authorBy Ramit Sethi
DateMar 15, 2026
Read time3 min

Piper Sandler has reiterated its 'Neutral' rating for e.l.f. Beauty (ELF) after reviewing adjusted data for February, which showed a minor slowdown in product consumption growth. Despite this, the beauty brand demonstrated strong overall performance in its recent financial quarter. The company continues to gain market share and expand its presence across various sales channels, affirming its position as a leading player in the cosmetics industry.

Piper Sandler has upheld its 'Neutral' recommendation for e.l.f. Beauty (ELF), a decision that follows an assessment of adjusted sales figures for February. The revision indicated that e.l.f. product consumption growth moderated slightly to 6%, a two-point decrease from January's pace. Nevertheless, the company's fiscal Q4 year-to-date performance remains strong, with an approximate 7% increase, mirroring the results from Q3. Concurrently, the broader U.S. mass cosmetics market experienced stable, albeit modest, single-digit growth, with Q4 year-to-date showing a slight acceleration compared to the previous quarter. The firm's maintained stance reflects a balanced view of e.l.f. Beauty's recent operational trends and market positioning.

e.l.f. Beauty's Robust Financial Performance and Market Position

e.l.f. Beauty showcased impressive financial results for the third quarter of fiscal year 2026, ending December 31, 2025. During this period, the company achieved significant market share gains for its e.l.f. Cosmetics brand, securing an additional 130 basis points. This growth trajectory was further amplified by the successful launch of its Rhode line in Sephora U.K., contributing to 28 consecutive quarters of category-leading expansion. The company reported a substantial 38% rise in net sales, reaching $489.5 million, propelled by strategic expansion across both domestic and international retail and e-commerce channels, indicating strong consumer demand and effective market penetration.

The company's third-quarter fiscal 2026 earnings, announced on February 4, 2026, highlighted a 38% surge in net sales to $489.5 million. This notable growth was fueled by significant market share gains, with e.l.f. Cosmetics adding 130 basis points, and a successful international debut of the Rhode line at Sephora U.K. The company sustained its impressive streak of category-leading growth for 28 consecutive quarters, showcasing its consistent ability to innovate and capture market demand. Despite a slight dip in gross margin by 30 basis points to 71% due to elevated tariff costs, pricing strategies and product mix improvements partially offset this impact. Selling, general, and administrative (SG&A) expenses increased, yet adjusted SG&A saw a rise to $249.2 million. With a robust cash reserve of $196.8 million and $816.7 million in long-term debt as of December 31, 2025, e.l.f. Beauty revised its fiscal 2026 net sales growth outlook upward to 22–23%, demonstrating strong confidence in its future performance and market expansion strategies.

More Articles
UBS Cuts Berkshire Hathaway Target Amidst Quarterly Setbacks
UBS has lowered its price target for Berkshire Hathaway's Class A shares to $866,429 from $880,905, while maintaining a Buy rating. This adjustment follows weaker-than-expected quarterly results and a cautious outlook for the reinsurance sector. Despite these challenges, the firm anticipates Berkshire Hathaway's stock to perform well in uncertain geopolitical environments, citing its diverse earnings, strong liquidity, and U.S.-centric operations. UBS also foresees management prioritizing margin improvements at BNSF, enhancing GEICO's retention, and upholding disciplined pricing in reinsurance for 2026–2027.
By Scott PapeMar 15, 2026
Barclays Upgrades Willis Towers Watson Amidst AI-Driven Industry Shifts
Barclays has elevated its rating for Willis Towers Watson Public Limited Company (WTW) to 'Equal Weight,' increasing its price target to $341 from $318. This adjustment reflects the firm's belief that concerns over AI's impact on the insurance brokerage sector are overstated. Barclays highlights WTW's robust specialist approach and the potential for AI to enhance efficiency and profitability, advocating for the underlying strength of the brokerage model.
By Natalie PaceMar 15, 2026
BofA Raises Eni S.p.A. Price Target, Citing Increased Oil and Gas Forecasts
Bank of America (BofA) has increased its price target for Eni S.p.A. (E) from EUR 18.50 to EUR 21, maintaining a Neutral rating. This adjustment reflects BofA's revised oil and gas price forecasts for 2026-27, driven by potential disruptions in the Strait of Hormuz. Eni recently reported robust Q4 2025 results, with a 35% year-over-year increase in adjusted net income and strong cash flow, alongside strategic operational agreements.
By Scott PapeMar 15, 2026
Barclays Raises Diamondback Energy (FANG) Price Target to $190, Citing Increased Oil Price Estimates
Barclays has increased its price target for Diamondback Energy (FANG) from $185 to $190, maintaining an Overweight rating. This adjustment reflects the firm's revised 2026 oil price estimates, influenced by the Iran conflict. Barclays believes the market is underestimating the cash flow benefits and the sustained positive impact on cash returns for exploration and production companies, even if the oil price surge is temporary.
By Scott PapeMar 15, 2026
RBC Lowers eHealth (EHTH) Price Target to $3 on Softened 2026 Projections
RBC Capital has decreased its price target for eHealth, Inc. (EHTH) from $9 to $3, maintaining a Sector Perform rating. This adjustment follows a revised, softer revenue outlook for 2026, despite strong fourth-quarter 2025 results. The revised forecast is primarily attributed to conservative expectations for the upcoming annual enrollment period and reduced marketing investment from a significant Medicare Advantage insurer.
By JL CollinsMar 15, 2026